Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril

Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril

Aim. To assess eft ventricular (LV) contractility dysfunction in patients with chronic lymphocytic leukemia (CLL) receiving chemotherapy with fludarabine, cyclophosphamide, and rituximab (FCR), and to determine the enalapril.effectiveness for their treatment.Material and methods. The study included...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. L. Davydkin, T. P. Kuzmina, I. A. Zolotovskaya, O. V. Tereshina, O. E. Danilova, R. K. Khairetdinov, L. A. Rogozina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-03-01
Series:	Российский кардиологический журнал
Subjects:	chronic lymphocytic leukemia subclinical left ventricle contractile dysfunction cardiotoxicity chemotherapy enalapril
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3480
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Noninvasive identification and therapeutic implications of supernormal left ventricular contractile phenotype
by: Yi Wang, et al.
Published: (2024-06-01)

COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION
by: Yu. I. Grinshtein, et al.
Published: (2016-01-01)

Enalapril in patients after mitral valve replacement
by: O. L. Barbarash, et al.
Published: (2007-08-01)

Enalapril and endothelial function in arterial hypertension patients of various age
by: L. I. Katelnitskaya, et al.
Published: (2005-12-01)

THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM
by: I. G. Fomina, et al.
Published: (2016-01-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

Two-year follow-up of patients with heart failure with reduced ejection fraction receiving cardiac contractility modulation
by: M. A. Vander, et al.
Published: (2020-08-01)

Child’s heart development and contractility from prenatal to postnatal period
by: E. N. Pavlyukova, et al.
Published: (2022-02-01)

Evaluation of the Hepatotoxicity Induced by Captopril and Enalapril in Rat Liver: A Comparative Study
by: Mohammed Ibrahim, et al.
Published: (2023-12-01)

FUNCTIONAL STATE DYNAMICS OF BLOOD CELLS AND ENDOTHELIUM IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ENALAPRIL TREATMENT
by: O. M. Moisseyeva, et al.
Published: (2003-12-01)

DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION?
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure
by: A. A. Petrukhina, et al.
Published: (2016-11-01)

COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS
by: O. M. Moiseeva, et al.
Published: (2016-01-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE
by: M. V. Ilyin, et al.
Published: (2015-12-01)

Untargeted metabolic analysis in serum samples reveals metabolic signature in children with congenital heart failure on enalapril therapy
by: N. J. L. Smeets, et al.
Published: (2025-04-01)

Dynamics of contractile function of the left atrium in patients, suffering ischemic mitral regurgitation
by: S. I. Musayev, et al.
Published: (2021-11-01)

Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System
by: Shota Yanagida, et al.
Published: (2025-08-01)

Changes in local left and right ventricular myocardial contractility in patients with recurrent atrial fibrillation
by: I. G. Fomina, et al.
Published: (2006-04-01)

Preservation of contractile reserve of the free wall of the left ventricle one of the main predictors for response to cardiac resynchronization therapy
by: M. V. Zlobina, et al.
Published: (2012-06-01)

Сoronary paradox
by: V. V. Chestukhin, et al.
Published: (2022-12-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

A STUDY OF CLINIC EQUIVALENCE OF TWO DRUG FORMS OF ENALAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. P. Kutishenko, et al.
Published: (2003-10-01)

THE RELATIVE INFLUENCE OF ENALAPRIL AND LOSARTAN ON THE DIURNAL PROFILE OF ARTERIAL PRESSURE IN HYPERTENSIVE PATIENTS
by: V. A. Azizov, et al.
Published: (2012-03-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

COMPARATIVE EVALUATION OF ENALAPRIL AND DILTIAZEM EFFICACY IN MENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2015-12-01)

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION
by: O. D. Ostroumova, et al.
Published: (2015-05-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study
by: Jelena Ivanovic, et al.
Published: (2025-08-01)

COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME
by: M. N. Mamedov, et al.
Published: (2016-01-01)

COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)

Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy
by: K. Y. Zholdoshov, et al.
Published: (2010-10-01)